Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$60.27M
↑ 153% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
$-113.50M
Historical baseline
PeriodValueYoY Change
2025$60.27M+696.3%
2024$7.57M+105.0%
2023$-150.11M+14.9%
2022$-176.35M+20.6%
2021$-222.14M-84.6%
2020$-120.33M-35.6%
2019$-88.73M+56.6%
2018$-204.32M-22.7%
2017$-166.53M-124.0%
2016$-74.35M-